Weekly News Roundup: July 26, 2019
Our focus in this week’s news roundup is precision medicine: four trends to make it possible; a precision medicine approach to cognitive disease treatment; how real-world data (RWD) and evidence are becoming more prominent in clinical research; and, does precision medicine have a minority problem?
Taking a Precision Medicine Approach to Cognitive Disease Treatment
Applying precision medicine tactics to cognitive disorder treatment and prevention efforts could improve outcomes, but researchers and providers will need a comprehensive understanding of the many risk factors that contribute to brain health, according to a study published in Frontiers in Aging Neuroscience. Read More
Precision Medicine: Four Trends Make It Possible
Precision medicine stands to deeply transform healthcare by tailoring care precisely to the individual, taking into account such personal characteristics as ethnicity, local environmental exposures, immunization history, and more. Read More
Does Precision Medicine Have A Minority Problem?
Precision medicine holds the potential to revolutionize healthcare. In spite of its promise and success, however, personalized medicine could inadvertently create new disparities. This is due to the fact that almost 80 percent of individuals who have contributed DNA to genomics research are Caucasian. Read More
Precision Medicine Is Crushing Once-Untreatable Cancers. But Only a Fraction of Patients Benefit.
For tens of thousands of patients, precision medicine is rewriting their cancer stories. The days when cancer patients received one-size-fits-all regimens of chemotherapy and radiation may soon be a thing of the past. Instead, doctors are taking a far more nuanced view of what drugs and treatments will work on which patients and on what different kinds of cancers. Read More
Real-World Data, Evidence Becoming More Prominent in Clinical Research
Real-world evidence (RWE) and real-world data (RWD) are already being used in a variety of ways to improve patient care and search for disease cures, participants said at a workshop here sponsored by the FDA and the American Association for Cancer Research. Read More